Premium
IC‐P‐006: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY)
Author(s) -
Ramusino Matteo Cotta,
Altomare Daniele,
Assal Frederic,
Mendes Aline,
Costa Alfredo,
Morbelli Silvia,
Bauckneht Matteo,
Picco Agnese,
Dottorini Massimo Eugenio,
Farotti Lucia,
Moretti Davide,
Savelli Giordano,
Tarallo Anna,
Parnetti Lucilla,
Nobili Flavio Mariano,
Parapini Maura,
Salvatore Elena,
Salvatore Marco,
Boccardi Marina,
Frisoni Giovanni B.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2070
Subject(s) - medicine , dementia , biomarker , amyloid (mycology) , etiology , disease , pathology , neuropsychology , oncology , cognition , psychiatry , biochemistry , chemistry
Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands; Alzheimer Center, VU University Medical Center, Amsterdam, Netherlands; VU University Medical Center, Alzheimer Center, Amsterdam Neuroscience, Amsterdam, Netherlands; Erasmus Medical Center, Rotterdam, Netherlands; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands; Neuroscience Campus Amsterdam, Amsterdam, Netherlands; Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands; Institutes of Neurology and Healthcare Engineering, UCL, London, United Kingdom; Amsterdam Neuroscience, VU University Medical Center, Amsterdam, Netherlands. Contact e-mail: l.collij@vumc.nl